• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Wellcome Open Res . First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary

tetano

Editor, Senior Moderator
Wellcome Open Res


. 2023 Jun 9;8:70.
doi: 10.12688/wellcomeopenres.18735.2. eCollection 2023. First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY

Lisa E Hopcroft[SUP] 1 [/SUP], Helen J Curtis[SUP] 1 [/SUP], Andrew D Brown[SUP] 1 [/SUP], William J Hulme[SUP] 1 [/SUP], Colm D Andrews[SUP] 1 [/SUP], Caroline E Morton[SUP] 1 [/SUP], Peter Inglesby[SUP] 1 [/SUP], Jessica Morley[SUP] 1 [/SUP], Amir Mehrkar[SUP] 1 [/SUP], Sebastian C Bacon[SUP] 1 [/SUP], Rosalind M Eggo[SUP] 2 [/SUP], Viyaasan Mahalingasivam[SUP] 2 [/SUP], Edward P K Parker[SUP] 2 [/SUP], Laurie A Tomlinson[SUP] 2 [/SUP], Christopher Bates[SUP] 3 [/SUP], Jonathan Cockburn[SUP] 3 [/SUP], John Parry[SUP] 3 [/SUP], Frank Hester[SUP] 3 [/SUP], Sam Harper[SUP] 3 [/SUP], Ben Goldacre[SUP] 1 [/SUP], Alex J Walker[SUP] 1 [/SUP], Brian MacKenna[SUP] 1 [/SUP]



Affiliations
Abstract

Background: The coronavirus disease 2019 (COVID-19) vaccination programme in England was extended to include all adolescents and children by April 2022. The aim of this paper is to describe trends and variation in vaccine coverage in different clinical and demographic groups amongst adolescents and children in England by August 2022. Methods: With the approval of NHS England, a cohort study was conducted of 3.21 million children and adolescents' records in general practice in England, in situ and within the infrastructure of the electronic health record software vendor TPP using OpenSAFELY. Vaccine coverage across various demographic (sex, deprivation index and ethnicity) and clinical (risk status) populations is described. Results: Coverage is higher amongst adolescents than it is amongst children, with 53.5% adolescents and 10.8% children having received their first dose of the COVID-19 vaccine. Within those groups, coverage varies by ethnicity, deprivation index and risk status; there is no evidence of variation by sex. Conclusion: First dose COVID-19 vaccine coverage is shown to vary amongst various demographic and clinical groups of children and adolescents.

Keywords: Covid-19; Primary Health Care; Public Health; vaccine.

 
Back
Top Bottom